Weight-Loss Peptides: A Queen of Herbs Guide

A lot of people have asked about weight-loss peptides lately - Ozempic, semaglutide, tirzepatide, all of it. Are they safe? Which one's best? Should you try one?

Instead of answering that one at a time, I'm working through it properly, one piece at a time, starting broad and then going drug by drug: what it does, how it works, what the research actually shows, and what it costs you - money and otherwise.

This page is the hub. New sections land here as they're ready - jump to whatever's live below.

What Peptides Actually Are

Before I get into the biochemistry: this is educational, not a recommendation to take any of these. I don't recommend pharmaceuticals to fix health problems - the real work is in how we live, what we eat, how we move, how we sleep, and what we're actually stressed about.

But that's the ideal, and the reality is that millions of people are using these peptides right now, and millions more will. If you're going to be one of them, you deserve to go in informed instead of chasing the before-and-after photos plastered all over social media.

What a peptide is - and why lab-made isn't the same as body-made

A peptide is a short chain of amino acids. Your body makes them constantly - insulin, oxytocin, the hormone that tells your brain you're full. They're messengers, and they work because they're embedded in feedback systems: your body makes them on demand, breaks them down on schedule, and knows when to stop.

A lab-created peptide that mimics one of these isn't the same thing. Structurally similar doesn't mean functionally identical. Your body's version has feedback loops telling it when to stop producing. The synthetic version just persists - it doesn't have those stop signals, or the context of your entire system. Your body wasn't built to carry pharmaceutical concentrations of these molecules for days at a time, and that's the experiment currently running on millions of people.

The "breakthrough" part - and what it actually means

Scientists took naturally occurring hormones, tweaked their structure so they'd last longer instead of breaking down in minutes, and turned them into drugs. That tweak is the thing that makes them different from what your body produces - and it's also the problem.

The weight loss is real. The appetite suppression is real. The mechanism works, to varying degrees.

The question isn't "does this work." The question is what happens when you do this to a human body for five years, or ten.

Trials run for weeks or months. Real life runs for years. We don't have the full picture yet of what happens to metabolism, bone density, your long-term relationship with food, or your body's ability to regulate hunger on its own after years of pharmaceutical override. That's playing out in real time, and people are reporting things the original trials didn't catch.

The honest part about weight loss and these drugs

They say people who come off these drugs only regain about two-thirds of the weight, so on paper it still looks like a win. In reality; that's just when they stopped watching. A closer look at the numbers tells a different story.

Real-world data shows the regain keeps climbing the longer someone's off the drug, not flattening out anywhere near that one-year mark. One observational study tracked it out and found people were back up 4.5% of their body weight at three months, 5.9% at six months, 6.7% at nine months, and 7.5% at a year - and still rising, no plateau in sight.

Look further out and it gets worse. At two years, 23% of semaglutide users were back to their full starting weight, or heavier. And in one smaller cohort, 49% - almost half - had already exceeded their starting weight within just one year of stopping. (Wilding et al., Diabetes Obes Metab, 2022 - STEP 1 trial extension; Epic Research, 2026; real-world discontinuation study, AJMC)

Which is still a hell of a thing to find out after spending real money, month after month, sometimes for years - and ending up back where you started, or worse. That money's just gone. For nothing.

This is the part that matters most: if you're thinking about any of these, you need a plan before you start - not after you stop and the weight is already coming back.

You get to make your own choices, but I'd push back on "take the drug and the problem goes away" as the plan. Ask instead: how am I going to sustain this weight loss without being on a pharmaceutical forever? And if I can't answer that, is starting this drug actually solving anything, or just delaying the problem?

The unglamorous answer to weight management is the same as it's always been: protein intake, consistent strength training, sleep, stress management, and not eating food engineered to override your satiety signals. Some people have other factors at play, but those five things handle the vast majority of it.

If you're going to use one of these peptides anyway, use the time on the drug as a tool to build those habits - not as the solution itself. If you go in knowing the weight is likely to come back without an exit strategy, that might be exactly the incentive you need to take maintenance seriously before you're back where you started, or worse.

What every one of these peptides comes with - no exceptions

Every one of these peptides comes with risks. Some are on the label - nausea, diarrhea, pancreatitis. Some are showing up in adverse event reports that haven't made it to the label yet. And some haven't surfaced at all, because the drugs haven't been used long enough or broadly enough for the pattern to show.

It's tempting to put unlimited faith in the people in white coats and the bodies that govern them. Medical errors are the third leading cause of death in the U.S. - after heart disease and cancer, ahead of respiratory disease and stroke. (Makary & Daniel, BMJ, 2016)

The reason is largely that the system treats your health as a transaction, not you as a person. Drugs get approved because the trials looked good enough. I've been on the other side of these trials - I know firsthand how data points get "tweaked" or left out entirely because "it's not what we're looking for." Side effects get added to labels years later, once enough people report them. By then, millions have already been exposed.

If you're still deciding how much weight to put on the drug being handed to you, look at the history first:

• Cutter Polio Vaccine (1955). A supposedly inactivated polio vaccine that actually contained live virus. It paralyzed over 200 children and killed 10 before being pulled from the market within weeks. (CDC, polio history)
• Thalidomide (1957-1962). A sedative marketed for morning sickness, sold in roughly 46 countries. An estimated 10,000+ infants worldwide were born with severe birth defects before it was pulled. (FDA history office)
• Vioxx (1999-2004). An arthritis pain reliever, and one of the ugliest ones on this list. Merck's own internal documents from 1997 - two years before the drug was even approved - show executives strategizing how to design trials so a cardiovascular risk signal wouldn't show up. It showed up anyway, in 1999, and Merck knew. They kept selling it for four more years regardless. An FDA safety officer's own analysis put the damage at 88,000-139,000 excess cases of serious heart disease in the U.S., 30-40% of which were likely fatal. Merck ran the numbers on how many people it could hurt and decided the money was worth it. (Graham et al., The Lancet, 2005)
• Accutane (1982-ongoing). A severe acne drug. It causes birth defects in 35% or more of pregnancies exposed in the first trimester, according to the NIH-affiliated MotherToBaby teratology service. FDA's adverse event database has also accumulated tens of thousands of psychiatric adverse event reports over two decades, including thousands describing suicide or suicidal ideation - those are reports, not proof of causation, and acne patients already skew toward a population at higher baseline risk for depression, but the volume is hard to ignore. Still prescribed today, with a black-box warning. (MotherToBaby; JAAD, 2025)
• Fen-Phen (1996-1997). A weight-loss drug combination. Independent echocardiographic studies found heart valve damage in roughly 30% of users. Pulled within about a year. (Connolly et al., NEJM, 1997)
• DES (1938-1971). An estrogen drug prescribed to prevent miscarriage. An estimated 5-10 million people were exposed - the pregnant women prescribed it and the sons and daughters born of those pregnancies. Daughters carry an elevated (still rare) risk of a specific vaginal cancer; a testicular cancer link in sons has been observed but rests on thinner evidence. Pulled for pregnancy use after over 30 years. (CDC DES Update; NCI)
• Remdesivir (2020-present). Originally trialed for Ebola. In the 2019 trial, the remdesivir arm had a 53% mortality rate at 28 days - the highest of the four drugs tested, though Ebola itself is brutally lethal and every arm saw major deaths. It was dropped from the Ebola trial in 2019 in favor of two better-performing options - then emergency-approved for COVID-19 the following year. Still in use today. (Mulangu et al., NEJM, 2019)

If you decide to go forward - what to know before you start

Before you even talk to a prescriber, ask yourself:

• What's the actual problem I'm trying to solve? The number on the scale? How you feel at 3pm? Your labs? How you look in the mirror? All of it? The drug slows your stomach, suppresses appetite, changes cravings - it temporarily changes what you want to eat. When you stop, why you developed those eating patterns in the first place comes right back.
• What am I going to do differently about food, movement, and stress while I'm on this? The drug doesn't change your relationship with any of those - it suppresses the signal.
• How long am I planning to take this? If the answer is "forever," have you thought through what that means financially and physically?
• What's my plan for when I stop? If you don't have one, you already know what's most likely to happen.
• Am I doing this because I genuinely think it'll make me healthier, or because I saw someone else's result and want the same? Be honest with yourself.

And before you fill that prescription, ask your prescriber:

• What are the actual risks for my body, given my health history - not the general class risks, mine specifically? If they don't know, they should. If they don't care, find someone who does.
• How will you monitor me? Labs, imaging, follow-ups - at what intervals?
• What are the new adverse events showing up in FDA's reporting system (FAERS) that aren't on the label yet?
• What happens if I develop one of the serious side effects? What's the plan, and how much help is actually available, for how long?
• If I want to stop, what does that look like? Do we taper? How long does rebound weight gain typically take?

Don't let anyone put you off asking as many questions as you want. It's their job to answer, and to be held accountable. Asking isn't paranoid - it's how you make the best decision for your own long-term health.

I'll have the next section up in a couple of days: Semaglutide, the one everyone actually means when they say "Ozempic."

- Emily

Semaglutide (Ozempic)

This one's next. Semaglutide is the drug most people actually mean when they say "Ozempic" - I'm putting together the mechanism, the adverse event numbers, and the muscle-loss data now. Give me a couple of days and it'll be live right here.

Enjoyed this? Queen of Herbs publishes weekly.
Read more at Queen of Herbs →